Shukra Meditech Ltd
Tue 17/11/2026,15:58:40 | NSE : SHUKRAPHAR
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 82.50
Previous Close
₹ 82.23
Volume
3136682
Mkt Cap ( ₹ Cr)
₹ 3639.75
High
₹ 84.00
Low
₹ 82.15
52 Week High
₹ 84.80
52 Week Low
₹ 40.06
Book Value Per Share
₹ 2.33
Dividend Yield
0.01
Face Value
₹ 1.00
What's Your Call?
Collective community sentiment on Shukra Meditech Ltd
Your Vote -
Buy
57.14%
Hold
21.43%
Sell
21.43%
57.14%
14 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
82.25
4398
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
4398
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Shukra Meditech Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Shukra Meditech - Name Change
-
Shukra Meditech - Announcement under Regulation 30 (LODR)-Change of Company Name
-
Shukra Pharma. - Press Release
-
Shukra Pharma. - Press Release
-
Shukra Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Shukra Pharma. - Statement of deviation(s) or variation(s) under Reg. 32
-
Shukra Pharma. - Outcome of Board Meeting
-
Shukra Pharma. Q2 net profit zooms 572.69% at Rs 16.01 cr
-
Shukra Pharma. - Reg 32
-
Shukra Pharma. - Unaudited Financial Results For The Quarter Ended 30Th September 2026
-
Shukra Pharma. - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended 30Th September 2026
-
Shukra Pharma. - Update on board meeting
-
Shukra Pharma. - Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended September 2026
-
Shukra Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026
-
Shukra Pharma. - General Updates
-
Shukra Pharma. - Structural Digital Database
-
Shukra Pharma. - General Updates
-
Shukra Pharma. - Announcement under Regulation 30 (LODR)-Change of Company Name
-
Shukra Pharma. - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Shukra Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Shukra Pharma. - Outcome of Board Meeting
-
Shukra Pharma. - Board Meeting Outcome for Allotment Of Shares Pursuant To Conversion Of Warrants
-
Shukra Pharma. - General Updates
-
Shukra Pharma. - Clarification From The Company
-
Shukra Pharma. - Price movement
-
Shukra Pharma. - Clarification sought from Shukra Pharmaceuticals Ltd
-
Shukra Pharma. - Voting Results With Scrutinizer Report
-
Shukra Pharma. - Shareholders meeting
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Outcome of Board Meeting
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Trading Window
-
Shukra Pharma. - Corrigendum To Postal Ballot Notice
-
Shukra Pharma. - Record Date
-
Shukra Pharma. has declared 1% Final dividend for the financial year March 2026
-
Shukra Pharma. - Shareholders meeting
-
Shukra Pharma. - Reg. 34 (1) Annual Report.
-
Shukra Pharma. - AGM NOTICE
-
Shukra Pharma. - General Updates
-
Shukra Pharma. - Update On Date Of AGM
-
Shukra Pharma. - General Updates
-
Shukra Pharma. - Announcement under Regulation 30 (LODR)-Dividend Updates
-
Shukra Pharma. - Outcome of Board Meeting
-
Shukra Pharma. - Board Meeting Outcome for Allottment Of Preference Shares
-
Shukra Pharma. - Copy of Newspaper Publication
-
Shukra Pharma. - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
-
Shukra Pharma. - Shareholders meeting
-
Shukra Pharma. - Outcome of Board Meeting
-
Shukra Pharma. - Board Meeting Outcome for AGM And Change Of Name
Key fundamentals
Evaluate the intrinsic value of Shukra Meditech Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 94.852 | 67.0125 | 60.7935 | 30.3783 | 19.7265 |
| Liabilities | 94.852 | 67.0125 | 60.7935 | 30.3783 | 19.7265 |
| Equity | 43.7879 | 43.7879 | 10.947 | 3.9142 | 1.5657 |
| Gross Profit | 28.7237 | 12.7297 | 19.4033 | 5.3633 | 2.8857 |
| Net Profit | 22.048 | 9.5751 | 18.5372 | 4.4065 | 0.7507 |
| Cash From Operating Activities | 3.1486 | 7.9184 | -5.1967 | 3.1695 | 7.7843 |
| NPM(%) | 38.88 | 29.38 | 24.85 | 7.48 | 3.66 |
| Revenue | 56.7061 | 32.5873 | 74.5729 | 58.8337 | 20.486 |
| Expenses | 27.9824 | 19.8576 | 55.1696 | 53.4704 | 17.6003 |
| ROE(%) | 21.34 | 9.27 | 17.94 | 4.26 | 0.72 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Shukra Meditech Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 768.70 | -1.31 | 15.26 | 46.94 | -26.19 | 0.65 |
| Lotus Eye Hospital and Institute Ltd | 104.96 | 3.73 | 477.09 | 171.05 | 0.39 | 0.00 |
| Vaishali Pharma Ltd | 7.18 | 2.28 | 18.41 | 1073.05 | 15.42 | 0.00 |
| Astec Lifesciences Ltd | 556.30 | 0.52 | 0.00 | 183.27 | -363.14 | 0.00 |
Company Info
1998 - Mrs. Riddhi M Patel, director of the company retires by rotation as per Provisions of the Act at this Annual General Meeting. 1999 - In accordance with the Companies Act, 1956 and Articles of Association of the Company, Mr. Mihir M Patel retire by rotation and is eligible for re-appointment. - Company has installed modern energy efficient machines. 2023 -Company issued rights shares of Rs. 10 in the ratio of 6:1 at a premium of Rs. 10 per share. 2024 -The Company has issued Bonus Shares in the Ratio of 3:1. 2025-The Company has splits its face value from Rs. 10/- to Rs. 1/-.-Shukra Pharmaceuticals bags Rs 24.06 cr Government-Backed Supply Contract for Afghanistan
1998 - Mrs. Riddhi M Patel, director of the company retires by rotation as per Provisions of the Act at this Annual General Meeting. 1999 - In accordance with the Companies Act, 1956 and Articles of Association of the Company, Mr. Mihir M Patel retire by rotation and is eligible for re-appointment. - Company has installed modern energy efficient machines. 2023 -Company issued rights shares of Rs. 10 in the ratio of 6:1 at a premium of Rs. 10 per share. 2024 -The Company has issued Bonus Shares in the Ratio of 3:1. 2025-The Company has splits its face value from Rs. 10/- to Rs. 1/-.-Shukra Pharmaceuticals bags Rs 24.06 cr Government-Backed Supply Contract for Afghanistan
Read More
Parent Organisation
Shukra Meditech Ltd.
Founded
04/03/1993
Managing Director
Mr.Dakshesh Rameshchandra Shah
NSE Symbol
SHUKRAPHAREQ
FAQ
The current price of Shukra Meditech Ltd is ₹ 82.25.
The 52-week high for Shukra Meditech Ltd is ₹ 84.00 and the 52-week low is ₹ 82.15.
The market capitalization of Shukra Meditech Ltd is currently ₹ 3639.75. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Shukra Meditech Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Shukra Meditech Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Shukra Meditech Ltd shares.
The CEO of Shukra Meditech Ltd is Mr.Dakshesh Rameshchandra Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.